Find Zidebactam manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 1436861-97-0, Wck-5107, Zidebactam, (-)-, Zidebactam [inn], Wck5107, Ypm97423db
Molecular Formula
C13H21N5O7S
Molecular Weight
391.40  g/mol
InChI Key
YCZPXRQPDCXTIO-BBBLOLIVSA-N
FDA UNII
YPM97423DB

Zidebactam
Zidebactam is under investigation in clinical trial NCT02674347 (MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous Zidebactam in Healthy Adults).
1 2D Structure

Zidebactam

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[(2S,5R)-7-oxo-2-[[[(3R)-piperidine-3-carbonyl]amino]carbamoyl]-1,6-diazabicyclo[3.2.1]octan-6-yl] hydrogen sulfate
2.1.2 InChI
InChI=1S/C13H21N5O7S/c19-11(8-2-1-5-14-6-8)15-16-12(20)10-4-3-9-7-17(10)13(21)18(9)25-26(22,23)24/h8-10,14H,1-7H2,(H,15,19)(H,16,20)(H,22,23,24)/t8-,9-,10+/m1/s1
2.1.3 InChI Key
YCZPXRQPDCXTIO-BBBLOLIVSA-N
2.1.4 Canonical SMILES
C1CC(CNC1)C(=O)NNC(=O)C2CCC3CN2C(=O)N3OS(=O)(=O)O
2.1.5 Isomeric SMILES
C1C[C@H](CNC1)C(=O)NNC(=O)[C@@H]2CC[C@@H]3CN2C(=O)N3OS(=O)(=O)O
2.2 Other Identifiers
2.2.1 UNII
YPM97423DB
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 1436861-97-0

2. Wck-5107

3. Zidebactam, (-)-

4. Zidebactam [inn]

5. Wck5107

6. Ypm97423db

7. 1,6-diazabicyclo(3.2.1)octane-2-carboxylic Acid, 7-oxo-6-(sulfooxy)-, 2-(2-((3r)-3-piperidinylcarbonyl)hydrazide), (1r,2s,5r)-

8. (1r,2s,5r)-7-oxo-2-(2-((r)-piperidine-3-carbonyl)hydrazine-1-carbonyl)-1,6-diazabicyclo[3.2.1]octan-6-yl Hydrogen Sulfate

9. [(2s,5r)-7-oxo-2-[[[(3r)-piperidine-3-carbonyl]amino]carbamoyl]-1,6-diazabicyclo[3.2.1]octan-6-yl] Hydrogen Sulfate

10. Unii-ypm97423db

11. Zidebactam [who-dd]

12. Chembl4533605

13. Schembl15886199

14. Schembl16151824

15. Gtpl10874

16. Yczpxrqpdcxtio-bbblolivsa-n

17. Amy30764

18. Ex-a5156

19. Wck 5107

20. Akos030573727

21. Db13090

22. Ms-26524

23. Hy-120859

24. Cs-0079386

25. Ns00073418

26. G16716

27. Q27294646

28. (2s,5r)-6-sulfooxy-7-oxo-2-[((3r)-piperidine-3-carbonyl)-hydrazinocarbonyl]-1,6-diaza-bicyclo[3.2.1]octane

2.4 Create Date
2014-09-22
3 Chemical and Physical Properties
Molecular Weight 391.40 g/mol
Molecular Formula C13H21N5O7S
XLogP3-4.2
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count8
Rotatable Bond Count4
Exact Mass g/mol
Monoisotopic Mass g/mol
Topological Polar Surface Area166
Heavy Atom Count26
Formal Charge0
Complexity694
Isotope Atom Count0
Defined Atom Stereocenter Count3
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty